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Objective: The purpose of this study was to examine the leukotoxin promoter types of Aggregatibacter actinomycetemcomitans clones in subjects with generalized aggressive 
periodontitis (GAgP) and in their family members (FM). Material and Methods: Thirty-five 
patients with GAgP (33.9±7.1 years), 33 of their FM (22.8±11.4 years), and 41 patients 
with chronic periodontitis (CP) (44.1±9.4 years) were clinically analyzed using the plaque 
index, gingival index, probing depth (PD), and clinical attachment level (CAL). Subgingival 
biofilm samples were collected from four interproximal periodontal sites (>PD and >CAL) 
of each patient. The presence of A. actinomycetemcomitans and its leukotoxic clone was 
confirmed by polymerase chain reaction (PCR). Results: A. actinomycetemcomitans was 
observed in 23 (51.1%) GAgP patients and 16 (30.1%) CP patients. Thirty-seven (94.8%) 
patients showed minimally leukotoxic strains and 2 (5.1%) showed highly leukotoxic 
strains. In the FM group, 10 (30.3%) had aggressive periodontitis (AgP), 12 (36.3%) 
had CP, 11 (33.3%) were periodontally healthy or had gingivitis, and 12.2% were A. 
actinomycetemcomitans positive. Greater full mouth PD and CAL were observed in GAgP 
patients positive for the bacteria than those negative for it (p<0.05), and the presence of 
A. actinomycetemcomitans positively correlated with GAgP (Odds ratio, 3.1; confidence 
interval, 1.4-7.0; p=0.009). Conclusions: The presence of A. actinomycetemcomitans was 
associated with the clinical condition of GAgP, with most patients exhibiting a generalized 
form of the disease and minimally leukotoxic clones. Most of the relatives of GAgP patients 
presented either CP or AgP.
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INTRODUCTION
Aggregatibacter actinomycetemcomitans is 
a gram-negative, capnophilic coccobacillus13, 
that is strongly associated with aggressive 
periodontitis (AgP)14. Despite being considered a 
periodontopathogen, A. actinomycetemcomitans 
can frequently be detected in periodontally healthy 
individuals, suggesting variability in its virulence20. 
The microorganism produces several virulence 
factors that may be involved in the destruction of 
periodontal tissues, the most important among them 
being the leukotoxic activity8,13.
Development of techniques to detect the 
genetic variability of microorganisms has allowed 
for the observation of genetic differences in the 
leukotoxin promoter region between various A. 
actinomycetemcomitans strains, which are directly 
correlated with their leukotoxicity34. Strains that are 
highly leukotoxic have a deletion of 530 base pairs in 
the leukotoxin promoter region, while those that are 
2013;21(5):430-6
J Appl Oral Sci. 431
minimally leukotoxic contain the complete leukotoxin 
promoter region. Thus, the highly leukotoxic 
strains (strain JP2) can produce 10 to 20-fold more 
toxin than the others, providing them with the 
potential to interfere with the host’s innate immune 
defense4. Some studies have shown that individuals 
harboring highly leukotoxic strains have a higher 
risk of AgP5,15,16, resulting in further progression of 
clinical attachment level (CAL)17,18. However, most 
of these studies assessed patients with localized 
AgP5,15,28,29,35, while only a few evaluated generalized 
AgP (GAgP)8,15,16.
Some studies have examined the transmission 
of A. actinomycetemcomitans between family 
members11,17,26,28. Besides genetic predisposition, 
transmission of A. actinomycetemcomitans can be 
considered a favorable hypothesis to explain the 
familial aggregation of individuals with AgP15,18. 
Patients who carried the JP2 clone were from families 
in which at least one other individual exhibited the 
disease5.
AgP is more prevalent in subjects of African 
ancestry, and it is hypothesized that besides host 
susceptibility, specific A. actinomycetemcomitans 
clones with enhanced leukotoxic activity are 
associated with the disease in these populations8. 
These particular clones could have been disseminated 
worldwide over centuries and might be related to 
the onset of AgP in different ethnic groups10,15. A 
study has shown that, in Brazil, skin color is not 
directly related to genomic ancestry23; the immense 
heterogeneity of the Brazilian population may 
make it difficult to predict race-related diseases 
or microorganisms. Indeed, the present study 
evaluated individuals from one of the three vast 
metropolitan areas of northeastern Brazil. Distinct 
from other populations that are predominantly 
African-American, this population is miscegenous, 
a blend over the years of white european, African-
American, and some indigenous populations, with 
no clear predominance of any race3.
Therefore, the evaluation of the periodontal and 
microbiological status of individuals with AgP in this 
population is relevant. The purpose of this study 
was to examine the leukotoxin promoter types of 
A. actinomycetemcomitans clones in subjects with 
GAgP and in their family members.
MATERIAL AND METhODS
Selection of subjects
This study was conducted in 35 patients with 
GAgP (test group) and one to four of their immediate 
family members (FM). A total of 33 relatives of 
26 GAgP patients were included. A group of 41 
patients with chronic periodontitis (CP) were used 
as the control group. Subjects were selected among 
patients who sought care at the Periodontology 
Clinic, Faculty of Pharmacy, Dentistry and Nursing, 
at the Federal University of Ceará, Brazil.
AgP patients were classified according to the 
clinical criteria suggested by the American Academy 
of Periodontology (AAP)30 as follows:
Localized AgP: interproximal attachment loss on 
at least two permanent teeth, involving no more than 
two teeth other than the incisors and the first molars;
GAgP: generalized interproximal attachment loss 
affecting three permanent teeth other than the first 
molars and incisors. The disease affects systemically 
healthy individuals and results in rapid attachment 
loss and bone destruction;
CP patients were also classified according to the 
criteria of the AAP14,21,22 as follows: 
Slight to moderate destruction: characterized 
by the presence of periodontal sites with a probing 
depth (PD) of up to 6 mm and CAL of up to 4 mm;
Advanced destruction: characterized by the 
presence of a PD greater than 6 mm and CAL greater 
than 4 mm.
exclusion criteria were as follows: periodontal 
treatment within the previous 6 months, antibiotic 
therapy within the previous 3 months, and systemic 
alterations that could have interfered with the 
periodontal conditions. The relatives of GAgP patients 
should have at least the first permanent molars.
The research protocol was approved by the ethics 
Committee, Federal University of Ceará, Brazil. All 
participants or guardians were informed about the 
purpose of the study and provided written consent.
Clinical measurements
Clinical measurements were made on all the 
completely erupted permanent teeth, except the 
third molars, using a periodontal probe (PCP-UNC 
15, Trinity, São Paulo, SP, Brazil). The following 
parameters were evaluated: plaque index1, gingival 
index1, PD, and CAL. PD and CAL were taken at six 
sites per tooth (mesiobuccal, buccal, distobuccal, 
mesiolingual, lingual, and distolingual). A single 
examiner evaluated all the clinical periodontal 
parameters, and the measurement reproducibility 
was calculated by using the intraclass correlation 
coefficient (ICC) for PD and CAL. The agreement 
between replicate measurements was high 
(ICC>0.80).
Microbiological sampling
The supragingival plaque was removed with 
curettes and sterile cotton pellets, and the area 
was isolated with sterile cotton rolls. Subgingival 
plaque samples were collected by means of two 
sterile paper points (size 35) at each site, for 20 
seconds (Dentsply Maillefer 35, Dentsply, Rio de 
Janeiro, RJ, Brazil) and stored separately. They 
were collected from four proximal tooth sites 
with greater CAL and increased PD. In FM without 
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periodontal disease, the subgingival plaque samples 
were collected from four proximal sites of the first 
permanent molars or incisors. All the samples were 
immersed in microtubes containing 1 mL of Ringer’s 
sterile solution9 and stored at -80°C until they were 
processed.
Microbiological evaluation
The microtubes containing the samples were 
thawed on ice. The bacterial cells or suspension were 
dispersed by vortexing at maximal setting for 1 min 
and centrifuged at 12,000x g for 10 min. Genomic 
DNA was extracted from the pellet (InstaGene 
Matrix, Bio-Rad Laboratories, Hercules, CA, USA) 
and 20 μL aliquot of the resultant supernatant was 
added to 30 μL of the reaction mixture containing 
25 μM polymerase chain reaction (PCR) buffer 
(Promega Corporation, Madison, WI, USA), 25 μM 
MgCl2 (Promega Corporation, Madison, WI, USA), 0.2 
μM dNTP mix (Promega Corporation, Madison, WI, 
USA), 1.25 U Taq polymerase (Promega Corporation, 
Madison, WI, USA), and 100 ng of each primer 
(Invitrogen, São Paulo, SP, Brazil), resulting in a 
final volume of 50 μL. Negative and positive controls 
were included in each reaction.
F i r s t ,  P C R  w i t h  s p e c i f i c  p r i m e r s 
( 5 ′ - G G A C T A Y A G G G T A T C T A A T - 3 ′ ; 
5′-AGAGTTTGATCMTGG-3′) for the 16S ribosomal 
DNA (16S rDNA) was performed to confirm the 
presence of bacterial DNA33. Subsequently, the 
samples were evaluated by PCR with specific primers 
for the presence of A. actinomycetemcomitans 
( 5 ′ -A A A C C C AT C T C T G A G TT C TT C TT C - 3 ′ ; 
5′-ATGCCAACTTGACGTTAAAT-3′)2. Once confirmed, 
the samples were analyzed for the presence of 
the leukotoxin operon using the primers ltx3 
(5′-GCCGACACCAAAGACAAAGTCT-3′) and ltx4 
(5′-GCCCATAACCAAGCCACATAC-3′) as previously 
described24. The primers resulted in amplicons of 
686 and 1.216 bp from strains of the JP2 clone and 
non-JP2 clone respectively, used as controls.
Amplification (Biocycler, Biosystems, Curitiba, PR, 
Brazil) of the 16S rDNA and A. actinomycetemcomitans 
DNA was performed at an initial cycle at 94°C for 10 
min, followed by 30 cycles at 96°C for 30 s, 55°C 
for 30 s and 72°C for 30 s, with the final extension 
at 72°C for 10 min15. For the leukotoxin promoter 
region, amplification was performed at an initial cycle 
at 94°C for 5 min, followed by 30 cycles at 94°C for 
1 min, 60°C for 1 min and 72°C for 2 min, followed 
by a final extension at 72°C for 8 min24.
The amplification products were analyzed by 
electrophoresis on an agarose gel and stained with 
ethidium bromide (10 μg/mL). A 1.5% gel was 
used to assess the 16S rDNA and the presence 
of A. actinomycetemcomitans, while a 2.0% gel 
was used to assess the A. actinomycetemcomitans 
clonal diversity. The gels were stained with ethidium 
bromide and photographed (Canon Powershot A640, 
Canon, USA) under ultraviolet light (LTA/LTB Ge, 
Loccus Biotecnologia, São Paulo, SP, Brazil).
PCR was repeated three times for each sample. 
JP2 (A. actinomycetemcomitans JP2) and non-JP2 
(A. actinomycetemcomitans HK1605) reference 
strains were used to determine the detection levels 
of the PCR method. The strains were serially diluted 
10-fold, followed by PCR as with the samples. The 
detection limits for A. actinomycetemcomitans 
and leukotoxin promoter region primers were 
approximately 102 and 103 colony-forming units 
(CFU) of the microorganism, respectively. These 
detection levels were similar to that described 
previously2,24.
Statistical analysis
The clinical data set was tested for normality 
using the Kolmogorov-Smirnov test. Comparisons 
between three groups (GAgP, CP, and RM) were made 
by ANOVA or Kruskal-Wallis. Comparisons between 
two groups (GAgP and CP) were made by the 
unpaired t-test or Mann-Whitney U test. Odds ratio 
(OR) analysis was used to assess the relationship 
between the presence of A. actinomycetemcomitans 
and the occurrence of AgP. A difference of p<0.05 
was considered statistically significant. All data 
analysis was performed using the GraphPad Instat 
software (Graph Pad Software Inc, San-Diego, CA, 
USA).
RESULTS
The sample comprised 109 individuals divided 
into three groups divided into GAgP, FM, and CP. 
Among the FM group, 10 had AgP, 12 had CP, and 11 
were periodontally healthy or had gingivitis (Figure 
Figure 1- Flowchart of the study population
AgP=aggressive periodontitis; CP=chronic periodontitis; 
H/G=periodontally healthy or gingivitis
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1). Among all the subjects with AgP (n=45), only one 
subject in the FM group presented localized AgP - a 
10-year-old boy, while others presented with GAgP.
Clinical data of the subjects are summarized in 
Table 1. A statistically significant difference between 
the ages of all groups was observed. The GAgP 
patients presented signs of more severe periodontal 
destruction and inflammation, as observed from 
the significantly higher mean PD than the CP and 
FM groups. CAL was also higher in the GAgP group 
followed by the CP group (Table 1).
In Table 2, all subjects, including the FM, were 
grouped based on their periodontal condition 
and the presence of A. actinomycetemcomitans. 
Twenty-three (51.2%) GAgP and 16 (30.2%) CP 
patients presented the bacteria. The presence of 
A. actinomycetemcomitans was associated with the 
clinical condition of AgP (OR, 3.1; confidence interval, 
1.4-7.0, p=0.009). Among the FM group, 3 patients 
with AgP and 1 with CP were positive for the bacteria. 
In healthy/gingivitis patients, the microorganism was 
not detected. Full mouth PD and CAL in GAgP patients 
positive for A. actinomycetemcomitans were higher 
than those in patients negative for it (p<0.05).
Among all the patients who were positive for 
A. actinomycetemcomitans, 37 (94.8%) exhibited 
minimally leukotoxic strains and 2 (5.1%), a man 
and a woman aged 37 and 31 years old, respectively, 
Parameters  GAgP FM  CP
N 35 33 41
Age (years) 33.9±7.1 22.8±11.4 44.1±9.4*
Number of teeth 25.0±2.3 24.2±5.3 22.0±3.5
PD fm (mm) 3.7±0.9* 2.4±0.5 2.9±0.5
CAL  fm (mm) 4.3±1.2*** 2.0±1.4 3.8±1.1
GI fm (%) 14.9±10.5 10.7±13.5 20.6±19.0**
PI fm (%) 32.3±19.7 24.8±19.6 33.5±14.0**
PD ss (mm) 9.8±2.1* 5.3±2.0 8.2±2.3
CAL ss (mm) 10.7±2.8*** 4.6±3.3 9.4±2.9
Table 1- Clinical periodontal parameters (mean± standard deviation) of subjects with generalized aggressive periodontitis 
(GAgP), chronic periodontitis (CP), and their family members (FM)
*Statistically significant difference between the groups
**Statistically significant difference between the CP and FM groups
***Statistically significant difference between the groups, except GAgP and CP
PD: probing depth; CAL: clinical attachment level; GI: gingival index; PI: plaque index; fm: full mouth; ss: sampled sites for 
microbial analysis
Parameters AgP CP H/G
Aa+ Aa- Aa+ Aa- Aa+ Aa-
N 23* 22 16 37 - 11
% 51.2% 48.8% 30.2% 69.8% - 100%
Age (years) 33.5±7.5 28.7±10.0 43.1±9.9 41.1±10.6 - 12.7±3.3
PD fm (mm) 3.8±0.9** 3.2±0.7 2.9±0.5 2.7±0.5 - 1.9±0.2
CAL fm (mm) 4.4±1.3** 3.6±0.9 3.7±1.1 3.5±1.2 - -
PD ss (mm) 9.7±2.6 8.5±2.0 8.1±2.0 7.5±2.4 - 3.3 ± 0.9
CAL ss (mm) 10.5±3.5 9.1±2.5 9.4±2.8 8.4±3.0 - -
Table 2- Clinical periodontal parameters (mean± standard deviation) and the presence of A. actinomycetemcomitans in all 
subjects with aggressive periodontitis (AgP), chronic periodontitis (CP) or periodontally healthy/gingivitis (H/G)
*Statistically significant association (odds ratio, 3.1; confidence interval, 1.4–7.0; p=0.009). Groups that exhibited highly 
leukotoxin strains
** Statistically significant difference between AgP
PD: probing depth; CAL: clinical attachment level; fm: full mouth; ss: sampled sites for microbial analysis; Aa+: presence 
of A. actinomycetemcomitans; Aa-: absence of A. actinomycetemcomitans
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exhibited highly leukotoxic strains with GAgP. The 
woman was screened subsequent to her brother 
being diagnosed with GAgP.
DISCUSSION
This study aimed to evaluate the presence of 
A. actinomycetemcomitans along with high or low 
leukotoxicity clones in GAgP patients and their close 
relatives. The results indicate an association between 
the presence of A. actinomycetemcomitans and the 
occurrence of GAgP, since 51.1% of patients with this 
disease (mean age: 33.5 years) were positive for 
the microorganism. Several studies have described 
the occurrence of A. actinomycetemcomitans in 
periodontal disease conditions similar to GAgP. This 
microorganism was found in 55% of patients (age 
range: 14-52 years)27, and in 20% of adults (range 
25-35 years)19.
However, only two patients with GAgP presented 
the highly leukotoxic A. actinomycetemcomitans 
clone, while 21 patients (91.3%) with the disease 
harboring the microorganism exhibited minimally 
leukotoxic clones. In accordance with previous 
studies8,12,15,16,20,29 they also presented periodontal 
destruction. Surprisingly, both the patients who 
harbored the leukotoxic clone were over 30 years of 
age. Highly leukotoxic clones are strongly associated 
with localized AgP5,15,16,35. Since this disease is 
associated with a young age, it could be hypothesized 
that the JP2 clone has a predilection for younger 
subjects. Patients harboring the highly leukotoxic 
strains were much younger (mean age: 12.7 
years) than those harboring the minimally toxic A. 
actinomycetemcomitans (mean age: 25.5 years)35. 
It was also observed that subjects with a mean age 
of 13.9 years were more frequently infected by the 
JP2 clone, while subjects with a mean age of 35.4 
did not show the infection15; these results were 
corroborated by the observations of our present 
study (mean age: 33.9 years).
Highly leukotoxic strains were not found in 
patients with periodontitis with mean age of 
33.6 years20. In another study, 12 out of 94 
A. actinomycetemcomitans-positive individuals 
exhibited the JP2 clone, but only one patient was 
over 30 years8. Among 131 Moroccan schoolchildren 
positive for A. actinomycetemcomitans, 11.5% 
presented the JP2 clone16. However, their age ranged 
between 14 and 19 years, much younger than those 
with AgP evaluated in our current study. Two specific 
studies revealed the prevalence of the leukotoxic 
clones in Brazil; both studies associated the young 
age of the subjects with the prevalence of highly 
leukotoxic clones of this microorganism10,29.
Results from cross-sectional10,15 and cohort 
studies5,35 have demonstrated that the JP2 clone can 
serve as a risk marker for localized AgP in children 
and adolescents. However, in the current study, 
the two JP2 clone positive patients were older than 
what has been described by other authors. Infection 
with the JP2 clone may have resulted in disease 
onset at a young age, but it may not necessarily 
be required for the maintenance of the disease17. 
One explanation for this is that for a majority of 
the patients evaluated in this study, their clinical 
periodontal examination was their first ever dental 
appointment. Lack of treatment resulted in the highly 
leukotoxic clone being present even at a later age. 
Another explanation is that the JP2 infection affects 
the immune tolerance, while other bacteria in the 
biofilm can sustain and maintain the inflammatory 
process, which manifests clinically as attachment 
and bone loss around the teeth. The JP2 clone may 
be constantly present below the limit of detection, 
while maintaining the activity of bone resorption17. 
On the other hand, we can hypothesize that the 
clones can cause periodontal destruction in older 
subjects as well. However, being a cross-sectional 
investigation, estimating the onset of the periodontal 
destruction is difficult.
The microbiological analyses of this study were 
performed by PCR that only provides information 
on the presence or absence of the microorganism’s 
DNA, unlike the quantitative data obtained by 
real-time PCR. However, the detection level of A. 
actinomycetemcomitans and its leukotoxin operon 
was determined to be around 102 and 103 CFU, 
respectively. The vast majority of studies on A. 
actinomycetemcomitans leukotoxin operon have 
been performed using the PCR technique4,8,12,14,16,17,29, 
which has been found to be highly reproducible and 
specific for analysis of the JP2 genotype17,24.
Another limitation of this study is the lack of 
a healthy group not related familiarly to the AgP 
patients. However, it has been shown that in the 
gingival sulcus of patients without clinical signs of 
inflammation there is a clear predominance of gram-
positive bacteria7,25. even when a more sensitive 
and specific technique was used (i.e. Human 
Oral Microbe Identification Microarray) and more 
subgingival sites sampled (14 teeth per patient), A. 
actinomycetemcomitans was not present among the 
species most commonly found in healthy subjects7.
In the present study, almost all the AgP patients 
were adults with a generalized disease and exhibited 
minimally leukotoxic A. actinomycetemcomitans 
clones. These patients, when younger, may have 
been colonized by highly leukotoxic strains and 
presented a localized disease, which may have 
begun with periodontal destruction. This is consistent 
with the hypothesis that there has been a change 
in the virulence of A. actinomycetemcomitans over 
time10,15. Haubek, et al.18 (2007) suggested that 
highly leukotoxic A. actinomycetemcomitans strains 
comprise a single clone. But, regarding minimally 
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leukotoxic strains, Wahasugui, et al.32 (2013) found 
that such strains belonged to 8 different biotypes.
A recent study in Sudanese adolescents 
(14-19 years) with AgP showed that the A. 
actinomycetemcomitans JP2 clone was not detected 
in any of the subgingival plaque samples, while non-
JP2 clones were detected in 70.6% of patients with 
the disease. It can also be suggested that the JP2 
clone does not show a general dissemination pattern 
among various African populations as previously 
believed12. The clone dispersed in America during 
the slave trade although not from all heritages; it 
mainly originated from the Mediterranean part of 
Africa18. This can help explain why some patients 
with the same pattern of disease do not present 
the JP2 clone. In the present study we evaluated 
a miscegenous population composed mainly of 
mixed afrodescendents, Caucasian europeans and 
indigenous Brazilians, with no predilection of race. 
even during the slave trade, identifying the African 
region that the subjects originated from was difficult. 
On arrival, subjects of different origins were sent to 
different regions of Brazil, which might explain the 
vast extent of mixed heritage among the Brazilian 
afrodescendents. A study has shown that in Brazil the 
race of a person and their genomic ancestry are not 
correlated23. This genetic variability in the Brazilian 
population may result in differences in susceptibility 
for colonization by certain microorganisms. This 
may also explain the low frequency of the highly 
leukotoxic A. actinomycetemcomitans clones found 
in these subjects.
Another point that can be identified as important 
in the etiology and spread of the disease is familial 
transmission of A. actinomycetemcomitans11,15,28; 
64% of the FM of AgP patients carried the 
microorganism11. On assessing Brazilian families of 
individuals with localized AgP, it was observed that 
41.2% of parents and 58% of siblings were also 
colonized by this bacteria and that 5% had the JP2 
clone28. Another study6 observed that in FM with 
localized AgP, the parents were diagnosed with CP 
and GAgP. Both parents and children of the subjects 
were always colonized by minimally leukotoxic A. 
actinomycetemcomitans clones6. In a Brazilian 
indigenous population, all A. actinomycetemcomitans 
strains were non-JP2 clones, even those originated 
from patients with periodontitis31.
The FM group consisted of 18 children and 
15 siblings of AgP patients. With regard to their 
periodontal status, 30.3% had AgP, 36.3% had 
CP, and 33.3% were periodontally healthy or had 
gingivitis. Among them, 12.2% were positive for A. 
actinomycetemcomitans, 10 had AgP, and 12 had CP. 
Only one (3%) exhibited a highly leukotoxic clone 
and three (9%) had minimally leukotoxic clones. 
Familial aggregation is one important characteristic 
of the various forms of AgP6. There is a consensus 
among researchers that genetic factors, with the 
possible influence of the environment, play a role 
in this disease6. In the present study, most of the 
close relatives had manifestations of AgP (30.3%) 
and CP (36.3%). By evaluating periodontal status 
and intrafamilial transmission of AgP, it was 
found that 38% of FM of AgP had some form of 
periodontal disease, 19% had AgP and 19% had 
CP11. According to these investigators, the parents 
and siblings of a patient with AgP who are positive 
for A. actinomycetemcomitans may exhibit increased 
susceptibility to destructive periodontal disease11.
CONCLUSION
I n  c o n c l u s i o n ,  t h e  p r e s e n c e  o f  A . 
actinomycetemcomitans was associated with 
GAgP. Most subjects with this disease harboring 
A. actinomycetemcomitans exhibited minimally 
leukotoxic clones, while most of the relatives of AgP 
patients presented either CP or GAgP.
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